Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2017-03-02 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于召开2016年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2016 Annual General Meeting (AGM) of Zhengzhou Antu Bioengineering Co., Ltd., including details on the meeting date, voting methods, agenda items, and proxy authorization. It does not contain the actual annual report or financial statements but rather the announcement and procedural information for the AGM. The document length is 3307 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2017-03-02 Chinese
第二届监事会第十次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhengzhou Antu Bioengineering Co., Ltd. It details the approval of various reports and proposals related to the 2016 fiscal year, including the Supervisory Board's work report, financial statements, profit distribution plan, remuneration schemes, and appointment of the audit firm for 2017. It also mentions that these items will be submitted to the 2016 Annual General Meeting for approval. The document is not the full annual report itself but a formal announcement of the Supervisory Board's meeting resolutions and approvals related to the annual report and other financial matters. It includes voting results and references to related disclosures on the stock exchange website. Given the nature of the content—meeting resolutions and approvals related to the annual report and financial matters but not the full report itself—this fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is relatively short (2157 characters) and focuses on resolutions and voting outcomes rather than detailed financial data or full report content, supporting this classification.
2017-03-02 Chinese
2016年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the 2016 annual report summary of Zhengzhou Antu Biological Engineering Co., Ltd. It contains detailed financial data for the year 2016, including total assets, revenue, net profit, earnings per share, and cash flow analysis. It also includes business descriptions, accounting policies, shareholder information, and notes on subsidiaries. The document is comprehensive and covers the company's full financial performance and business overview for the fiscal year 2016. It is not a brief announcement or a certification letter but a substantive financial report. Therefore, it fits the definition of an Annual Report (10-K). FY 2016
2017-03-02 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds. It details the company's purchase of financial products (wealth management products) from banks, including amounts, dates, and expected yields. The document is relatively short (1357 characters) and focuses on updates about financing activities related to cash management and investment of idle funds. There is no financial statement or comprehensive financial report included, nor is it an announcement of a report publication. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's financing activities and capital management.
2017-03-01 Chinese
关于全资子公司获得高新技术企业认定的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a subsidiary receiving a high-tech enterprise certification and the related tax benefits. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory announcement about a corporate event, not a financial report or meeting material. The document length is only 524 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-02-28 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds, specifically detailing purchases and redemptions of financial products (wealth management products) with banks. It includes specific transaction dates, amounts, and yields. The document is relatively short (1690 characters) and focuses on updates about financing activities related to cash management and investment products. There is no indication of it being a full financial report, audit, earnings release, or management discussion. It is not a regulatory certification or voting result. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's financing activities and capital management through wealth management products.
2017-02-21 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.